NIFTY 50 22795.9 ▼ (0.51%)
NIFTY NEXT 50 60466.8 ▼ (0.94%)
NIFTY 100 23274.05 ▼ (0.59%)
NIFTY MIDCAP 100 50486.2 ▼ (1.32%)
NIFTY SMALLCAP 100 15636.9 ▼ (0.7%)
NIFTY SMALLCAP 250 14683.4 ▼ (0.57%)
NIFTY MIDCAP SELECT 11198.9 ▼ (1.69%)
NIFTY TOTAL MARKET 11634.25 ▼ (0.67%)
NIFTY BANK 48981.2 ▼ (0.72%)
SENSEX 75311.06 ▼ (0.56%)
BSE BANKEX 55718.18 ▼ (0.82%)

PROCTER & GAMBLE HEALTH LIMITE

BSE: 500126 22 Feb 2025
Healthcare
₹ 5,276
PROCTER & GAMBLE HEALTH LIMITED specializes in Pharmaceuticals within the Healthcare sector.

PROCTER & GAMBLE HEALTH LIMITE - Share Price & Details

Market Cap
₹8,757
High /Low
5,850 / 4,637
Stock P/E
35.7
Book Value
₹368.0
Dividend Yield
1.52
ROCE
45.0
ROE
₹33.5
Face Value
10.0
PEG Ratio
-1.51
EVEBITDA
₹23.3
Debt
8.28
CMP / FCF
48.9
Debt to equity
₹0.01
NP Ann
201
High price all time
7,500
Piotroski score
₹7.0
Graham Number
1,086
No. Eq. Shares
1.66
Net CF
₹-197
Net profit
237
Price to book value
14.4
Interest Coverage
₹522.0
Low price all time
243.0
Industry PE
46.1
Reserves
₹594
Free Cash Flow
₹207

Price Chart


Volume Chart


Peer Comparison

Stock Net Sales EPS P/E
Shyama Computronics and Servic0.61NA30.9
Triochem Products Ltd.,NA3.60
PROCTER & GAMBLE HEALTH LIMITE3,097.7054.7635.7
Metropolis Healthcare Limited3227.676.0955.7
HealthCare Global Enterprises5,575.500.49125.0

Peer Comparison Chart


About PROCTER & GAMBLE HEALTH LIMITE

PROCTER & GAMBLE HEALTH LIMITED, with Security Code 500126, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Procter & Gamble Health Reports Strong Quarter Amid Long-Term Growth Challenges

(28 Jan 2025)
Procter & Gamble Health has recently experienced a change in evaluation, reflecting its financial position in the pharmaceuticals sector.
Read more →

Public companies invested in Procter & Gamble Health Limited (NSE:PGHL) copped the brunt of last week's ₹5.1b market cap decline

(02 Jan 2025)
Key Insights The considerable ownership by public companies in Procter & Gamble Health indicates that they collectively...
Read more →

Procter & Gamble Health Receives 'Hold' Downgrade Despite Strong Financial Metrics

(25 Dec 2024)
Procter & Gamble Health, a midcap player in the pharmaceuticals and drugs industry, has recently received a stock call downgrade to 'Hold'...
Read more →

Subdued Growth No Barrier To Procter & Gamble Hygiene and Health Care Limited's (NSE:PGHH) Price

(24 Dec 2024)
With a price-to-earnings (or "P/E") ratio of 71.6x Procter & Gamble Hygiene and Health Care Limited ( NSE:PGHH ) may be...
Read more →

Procter & Gamble Health Receives 'Buy' Rating and Shows Strong Financial Performance

(09 Dec 2024)
Procter & Gamble Health, a midcap pharmaceutical and drugs company, has recently caught the attention of investors as MarketsMOJO upgraded its stock call to...
Read more →

Procter & Gamble Hygiene and Health Care Ltd (PGHH) Share Price

(30 Nov 2024)
STOCK SUMMARY · Face Value (₹)10.00 · Beta0.24 · 52-Week Low (₹)15,345.40 · 52-Week High (₹)17,745.00 · Price-to-Book (X)*66.51 · Dividend Yield...
Read more →